Vitrolife AB (publ) (VTRLY)
OTCMKTS · Delayed Price · Currency is USD
15.00
0.00 (0.00%)
Oct 8, 2025, 8:00 PM EDT
Vitrolife AB Market Cap
Vitrolife AB has a market cap or net worth of $2.02 billion as of October 10, 2025. Its market cap has decreased by -37.78% in one year.
Market Cap
2.02B
Enterprise Value
2.14B
Revenue
372.37M
Ranking
n/a
PE Ratio
42.29
Stock Price
$15.00
Market Cap Chart
Since June 27, 2001, Vitrolife AB's market cap has increased from 47.59M to 2.02B, an increase of 4,152.36%. That is a compound annual growth rate of 16.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 2.02B | -23.22% |
| Dec 30, 2024 | 2.64B | 0.83% |
| Dec 29, 2023 | 2.61B | 8.07% |
| Dec 30, 2022 | 2.42B | -71.15% |
| Dec 30, 2021 | 8.38B | 193.22% |
| Dec 30, 2020 | 2.86B | 24.29% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 679.59M |
| Glass House Brands | 638.25M |
| Veradigm | 522.72M |
| Northwest Biotherapeutics | 373.50M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 331.81M |
| American Oncology Network | 287.67M |
| Silence Therapeutics | 247.98M |